Asymptomatic multifocal avascular necrosis, a commonly overlooked finding in patients with systemic lupus erythematosus
Open Access
- 18 December 2024
- journal article
- research article
- Published by Springer Nature in BMC Rheumatology
- Vol. 8 (1) , 70
Abstract
BackgroundIn patients with Systemic lupus erythematosus (SLE), osteonecrosis of various joints is a debilitating complication associated with the disease and its treatment, in which a considerable proportion of osteonecrosis may be asymptomatic. Recognizing the crucial role of early and timely detection, as well as appropriate management of asymptomatic osteonecrosis, in preventing joint destruction, we conducted a study to evaluate the prevalence of asymptomatic osteonecrosis in SLE patients who have already been diagnosed with symptomatic osteonecrosis. Additionally, we aimed to examine the relationship between proposed risk factors of osteonecrosis and the development of asymptomatic osteonecrosis.MethodsIn this cross-sectional study, Patients with recently diagnosed symptomatic osteonecrosis of at least one joint were selected by reviewing data from the digital medical record system of the Rheumatology Research Center. The patients underwent three-phase Single Photon Emission Computed Tomography (SPECT) bone scintigraphy to screen for other asymptomatic osteonecrotic joints. MRI was subsequently performed on the asymptomatic osteonecrotic sites for further diagnostic confirmation. The study evaluated the prevalence of asymptomatic osteonecrosis, the extent of joint involvement, the specific locations of osteonecrosis, the most commonly affected joints, and the risk factors for asymptomatic osteonecrosis.ResultsEight out of the 17 patients (47%) who participated in our research were found to have asymptomatic osteonecrosis. The most commonly affected joint without symptoms was the left knee (25%), while the most frequently affected joint with symptoms was the left hip (23.07%). The only statistically significant difference observed between patients with and without asymptomatic osteonecrosis in this study was the age at which the disease first appeared (p = 0.046) and this age was higher among patients with asymptomatic osteonecrosis.ConclusionsOur research provides further evidence of the high incidence of asymptomatic osteonecrosis in individuals with SLE due to the nature of the disease and the frequent use of high-dose corticosteroids. It underscores the importance of early detection through whole-body SPECT bone scintigraphy and MRI, as well as prompt intervention in order to avert the incapacitating effects of osteonecrosis.Keywords
This publication has 37 references indexed in Scilit:
- Predictors of Osteonecrosis in Systemic Lupus Erythematosus: A Prospective Cohort StudyArthritis Care & Research, 2020
- The 2019 Revised Version of Association Research Circulation Osseous Staging System of Osteonecrosis of the Femoral HeadThe Journal of Arthroplasty, 2020
- Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse EventsCurrent Rheumatology Reports, 2016
- The pathogenesis of multifocal osteonecrosisScientific Reports, 2016
- ACR Appropriateness Criteria Osteonecrosis of the HipJournal of the American College of Radiology, 2016
- High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature ReviewThe Journal of Arthroplasty, 2015
- Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview)Journal of Orthopaedic Translation, 2015
- Treatment of Osteonecrosis in Systemic Lupus Erythematosus: A ReviewCurrent Rheumatology Reports, 2014
- Pathogenesis and natural history of osteonecrosisSeminars in Arthritis and Rheumatism, 2002
- Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodiesRheumatology, 1998